申请人:Adapt Pharma Limited
公开号:US20170071851A1
公开(公告)日:2017-03-16
Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.